1,099 Companies

Access all companies

Find technology partners quickly.

Spotfolio tracks over one million companies in technology industries.

There are 1,099 companies in the field of Biopharma on spotfolio that produce or deliver products, that utilize or research technologies or that are otherwise engaged in topics such as Clinical, Drug, Dr, Research, Therapeutic, Patients, University, Pharmaceutical .

Start-ups (133)

Early-stage companies (322)

Established companies (568)

The majority of these companies is located in the following countries.

United States (576)

United Kingdom (94)

Canada (56)

Germany (45)

Example Companies

Find companies in your area

Mirati Therapeutics Mirati Therapeutics Inc.

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Contact - Email Alerts Scientific Advisory Board Stephen B. Baylin, MD Dr. Baylin is a leader in the field of epigenetics and has been investigating ...

therapeutic value for clinical examination of DNA methylation markers. Currently, Dr. Baylin is Virginia and D. K. Ludwig Professor in Cancer Research, Associate ...

Director of Cancer Center for Research, and Director Cancer Biology Program. Dr. Baylin’s laboratory has also identified chronic inflammation as a rapid promoter ...

Dream Team that he and Dr. Peter Jones currently lead. Early in his career, when he was at the National Heart and Lung Institute, Dr. Baylin also characterized ...

rare hereditary thyroid cancer. Dr. Baylin received his medical degree from Duke University. George D. Demetri, MD Dr. Demetri has long been a leader ...

well as Votrient and Yondelis for other sarcomas. In a related contribution, Dr. Demetri served on the Scientific Advisory Board for Plexxikon and was a critical

University of Windsor Ontario in Canada. Charles M. Baum, MD, PhD - Director Dr. Baum was appointed President and Chief Executive Officer and Board Member ...

Clinical Research within Pfizer’s Worldwide Research & Development division. Dr. Baum was at Pfizer from 2003 until joining Mirati in 2012, serving in roles ...

gastrointestinal stromal tumor (GIST) and renal cell carcinoma. Prior to joining Pfizer, Dr. Baum was responsible for the Phase I-IV development of several oncology compounds ...

Searle, Schering-Plough and Pfizer). Dr. Baum currently serves on the board of directors of Array BioPharma. Dr. Baum received his M.D. and Ph.D. (Immunology) ...

and completed his post-graduate training at Stanford University, California. Dr. Baum has received research support from the National Institutes of Health ...

and holds a number of patents and patent applications. Dr. Bruce L.A. Carter - Director Dr. Carter joined Mirati’s Board of Directors in September of

CelaCare Technologies

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

CelaCare BioPharma About Core Values People Business Philosophy Dr. Kenneth Yates Dr. Kenneth Yates, the principal founder of the company, serves as president ...

including significant experience in wound and oral care product development. Dr. Yates previously served as president of DelSite Biotechnologies, a drug delivery ...

delivery company prior to it being integrated back into its parent company. Dr. Yates left the company in 2006 becoming the founding chairman of the department ...

CelaCare. Dr. Yates also currently serves as a director for Piedmont Pharmaceuticals, LLC and Piedmont Animal Health, LLC. Dr. Celia Procter Dr. Celia Proctor ...

System Formulary Management and Integration, Johns Hopkins Health System. Dr. Proctor received her Doctor of Pharmacy degree from Harding University College ...

position her to advise the company as needed in support of operations. Dr. Daniel Atchley Dr. Daniel Atchley, co-founder of the company, is a medical microbiologist

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

The Team Dr Philip Huxley CEO Dr Philip Huxley is the founder of Ducentis BioTherapeutics, and a specialist in turning basic science into clinical candidates ...

with a former portfolio and collaborations manager at Immunocore (Dr Rebecca Ashfield). Dr Huxley led the team that discovered RhuDex, the compound which ...

MediGene's acquisition of Avidex for $64m. Before founding Ducentis in 2015: Dr Huxley was the Chief Technology Officer of Prexa Pharmaceuticals Inc (Boston ...

Belgium) where he was a co-inventor of the first Galapagos development candidate. Dr Huxley began his career at Novartis (Basel, Switzerland) where he worked on ...

design. Dr Huxley also provides leadership support to Bicycle Therapeutics (Cambridge, UK), another of the UK's most promising biotech companies. Dr Rebecca ...

Rebecca Ashfield CSO Dr Rebecca Ashfield has 16 years’ experience in the pharmaceutical industry where her work has focused on pre-clinical and clinical development

PRISM BioLab PRISM BioLab Inc.

established

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Management Hiroyuki Kouji, Ph.D., President & CEO The founder of PRISM, Dr. Kouji has more than 30 years of experience in drug discovery and product ...

Asahi-Kasei Pharma. Dr. Kouji received a Ph.D. in Pesticide Chemistry from Kobe University. Masamoto (Matt) Fujimori, M.D., Ph.D. Dr. Fujimori joined PRISM ...

of anti­allergy, anti­infective, cardiovascular and anti­neoplastic agents. Dr. Fujimori successfully completed to assist for 8 NDA filings and products ...

from University of Tokyo. Takenao Odagami, Ph.D., Vice President of R&D Dr. Odagami is a founding member of PRISM and has over 20 years of experience ...

and process chemistry. Formerly a Senior Researcher at Asahi-Kasei Pharma, Dr. Odagami received a Ph.D. in Medicinal Chemistry from Kobe-gakuin university ...

more than 25 years US clinical/industrial experience in Japan and the U.S. Dr. Inada previously held R&D and business development positions at Kyowa Hakko

Revere Pharmaceuticals Revere Pharmaceuticals Inc.

early-stage

Access

  • Technologies
  • Core data such as location, employees, revenues
  • Similar and peer companies
  • and more

Web Quotes

Arantes-Oliveira (PhD) Vice President of Business Development #gokabio Dr. Erik Goka (PhD) Senior Director of Biology Board of Directors #silvermanbio ...

Officer #palbio Kollol Pal (PhD, MBA) Robert Silverman (JD, PhD) President Dr. Silverman has been the President and co-founder of Revere Pharmaceuticals ...

from 2007 to 2017, helping the company become public in 2014. Previously, Dr. Silverman was Associate General Counsel at Millennium Pharmaceuticals (now ...

Vertex Pharmaceuticals and FMC Corporation. Dr. Silverman also lectures for the BIO Executive Training Programs. Dr. Silverman started his career as a research ...

research chemist. He has over 20 US patents. Dr. Silverman received his BA degree from Lehigh University, his PhD from the U of New Mexico and did post-doctoral ...

JD from Rutgers Law School. Jedd Levine (MD, MBA) Chief Medical Officer Dr. Levine is a medical oncologist and practiced clinical oncology for 30 years

Use detailed technology terms.

Only spotfolio allows for searching with detailed technology terms, as we provide you with all topics that technology companies talk about.

Companies addressing these topics might be of specific interest to you, as they share more specific, niche topics.

Use Cases

Register now

Why Technology Scouting?

Technology scouting is the basis for your innovation management, identifies new technological developments as early as possible and protects you from disruptive business models.

Identify technology partners

Boost your market research

Look beyond major players

Build long and short lists

Collect technology leaders, providers, start ups and potential new partners in lists via simple tagging to take further steps with your team.